Live from the NIH registry
Studies recruiting near Roanoke right now
Top 25 of 191 recruiting studies, sorted by proximity — each links to its official registry page
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Breast Cancer
Phase 2
Interventional 36 participants sought
Blue Ridge Cancer Care (Oncology & Hematology Assoc of SW Virginia, Inc) — Salem, Virginia (5.4 mi)
· Sponsor: SCRI Development Innovations, LLC
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Carilion Children's — Roanoke, Virginia (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
Carilion Roanoke Memorial Hospital — Roanoke, Virginia (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
BRCC/Oncology & Hematology Associates of SW Virginia — Blacksburg, Virginia (25.3 mi)
· Sponsor: Regeneron Pharmaceuticals
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Blue Ridge Cancer Center (Oncology & Hematology Associates of Southwest VA) — Salem, Virginia (5.4 mi)
· Sponsor: SCRI Development Innovations, LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Roanoke, Virginia (1.1 mi)
· Sponsor: Sameek Roychowdhury
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Blue Ridge Cancer Care — Roanoke, Virginia (1.1 mi)
· Sponsor: Pfizer
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
Prediabetic State, Atherosclerosis
Phase 4
Interventional 7,410 participants sought
Salem VA Medical Center, Salem, VA — Salem, Virginia (5.4 mi)
· Sponsor: VA Office of Research and Development
3D Printed Personalized Ostomy Appliance
3D Printing, Ostomy
N/A
Interventional 30 participants sought
Carilion Clinic — Roanoke, Virginia (1.1 mi)
· Sponsor: Carilion Clinic
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Roanoke, Virginia (1.1 mi)
· Sponsor: Akero Therapeutics, Inc
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Vistar Eye Center - Salem /ID# 282879 — Salem, Virginia (5.4 mi)
· Sponsor: AbbVie
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Mitral Valve Regurgitation
N/A
Interventional 1,056 participants sought
Carilion Roanoke Memorial Hospital — Roanoke, Virginia (1.1 mi)
· Sponsor: Medtronic Cardiovascular
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
VA O&P — Roanoke, Virginia (1.1 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
VA Medical Center_Salem — Salem, Virginia (5.4 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Salem VA Medical Center /ID# 262387 — Salem, Virginia (5.4 mi)
· Sponsor: AbbVie
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Aortoiliac Occlusive Disease
N/A
Observational 158 participants sought
Carilion Clinic — Roanoke, Virginia (1.1 mi)
· Sponsor: W.L.Gore & Associates
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
Blue Ridge Cancer Care ( Site 0067) — Roanoke, Virginia (1.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Carilion Children's — Roanoke, Virginia (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Phase 3
Interventional 1,314 participants sought
Blue Ridge Cancer Care ( Site 0004) — Roanoke, Virginia (1.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 10 — Blacksburg, Virginia (25.3 mi)
· Sponsor: Merus B.V.
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Oncology and Hematology Associates of Southwest Virginia, Inc (Us Oncology Research) — Blacksburg, Virginia (25.3 mi)
· Sponsor: BeOne Medicines
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Carilion Children's — Roanoke, Virginia (1.1 mi)
· Sponsor: PedAL BCU, LLC
The Role of the Locus Coeruleus in Age-related Distractibility
Aging, Alzheimer Disease
N/A
Interventional 200 participants sought
Virginia Polytechnic Institute and State University — Blacksburg, Virginia (25.3 mi)
· Sponsor: Virginia Polytechnic Institute and State University
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Carilion Clinic — Roanoke, Virginia (1.1 mi)
· Sponsor: Alleviant Medical, Inc.
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Vistar Eye Center - Roanoke - South Jefferson Street /ID# 276119 — Roanoke, Virginia (1.1 mi)
· Sponsor: AbbVie